Join
Live feed
·
INSIDERFilingvia Quantisnow
Jazz Pharmaceuticals plc logo

Director Smith Mark Douglas sold $266,746 worth of Ordinary Shares (1,157 units at $230.55) as part of a pre-agreed trading plan, decreasing direct ownership by 11% to 9,680 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track JAZZ (Jazz Pharmaceuticals plc) and more on Quantisnow.